Filed in archive
Drugs, Vaccines and Therapeutics
by ruth on January 20, 2006
TPM-01/Morphine is a non-invasive, patient-friendly gel that delivers morphine through the skin into the bloodstream. Its developers, Australia-based Phosphagenics announced the completion and positive results from an 18-patient single dose, open label, randomised study that examined its pharmacokinetics.
In the study, the morphine gel, administered via a single application to the upper arm, achieved therapeutic blood morphine levels within 2 hours and these were maintained for over 48 hours with full clearance occurring by 72 hours.
Phosphagenics claims that topical administration may have several advantages over oral administration, in that side effects commonly associated with oral administration of morphine such as constipation, nausea, and drowsiness are eliminated. Additionally, transdermal delivery could offer sustained delivery of morphine for chronic pain sufferers.
Phosphagenics now plans to seek approval for a Phase IIa trials to assess the product's efficacy in relief of post-operative pain. The trials are expected to commence in early 2006.
Source: Phosphagenics
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/14145
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for Transdermal Morphone Gel Shows Positive Phase IB Clinical Trials:
|
Rating: 8.50 out of 4 vote(s) cast.
|
Response from:
Are you a beauty?
TPM-01/Morphine is a non-invasive, patient-friendly gel that delivers morphine through the skin into the bloodstream. Its developers, Australia-based Phosphagenics announced the completion and positive results from an 18-patient single dose, open label...
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
